STOCK TITAN

HEALTHWAREHOUSE.COM - HEWA STOCK NEWS

Welcome to our dedicated page for HEALTHWAREHOUSE.COM news (Ticker: HEWA), a resource for investors and traders seeking the latest updates and insights on HEALTHWAREHOUSE.COM stock.

HealthWarehouse.com, Inc. (symbol: HEWA) is a prominent player in the online pharmaceutical industry, distinguished as America’s only Verified Internet Pharmacy Practice Site (VIPPS). Headquartered in the Cincinnati metropolitan area, the company is licensed and authorized to operate in all 50 states. HealthWarehouse.com is dedicated to addressing the growing out-of-pocket prescription market, with a core mission to make healthcare affordable and accessible for every American.

HealthWarehouse.com offers a wide range of FDA-approved prescription drugs and over-the-counter items, all of which are legal for sale in the United States. Customers can also find medications commonly available at veterinarian offices, making the company a versatile provider for both human and pet health needs.

The company prides itself on providing personalized service through a highly skilled team of professionals committed to delivering the highest quality of care. Recent achievements include expanding their product lines and enhancing their online platform to improve user experience and accessibility.

In terms of financial health, HealthWarehouse.com has shown consistent growth and stability, supported by strategic partnerships and a robust business model focused on customer satisfaction and affordability. Their ongoing projects aim to further simplify the prescription process, making it easier for customers to obtain essential medications without the hassle of traditional pharmacy visits.

Rhea-AI Summary

HealthWarehouse.com (OTC:HEWA) reported record Q3 2024 results with net sales of $9.0 million, an 89% increase from Q3 2023. The company achieved net income of $74,000 and Adjusted EBITDA of $405,000. Prescription sales grew 96.3% to $8.3 million, driven by strong growth in GLP-1 weight loss medications. Gross profit increased to $3.8 million, though margins decreased to 42% due to price competition. The company also secured extension of convertible note maturity to 2026, strengthening its capital position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

HealthWarehouse.com (OTC:HEWA) reported Q2 2024 results with net sales of $5.8 million, a 9% increase from Q2 2023. The growth was driven by strong performance in partner services and B2C prescription revenue, particularly from GLP-1 weight loss medications. However, the company posted a net loss of $344,000 for Q2 and $596,000 for H1 2024. Prescription sales rose 12.8% to $5.1 million in Q2, while over-the-counter sales decreased 14.3% to $643,000. Gross profit declined due to lower margins, but operating expenses decreased by 10.1%. The company's Adjusted EBITDA broke even for Q2, improving from a $152,000 loss in Q2 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

HealthWarehouse.com, Inc. (HEWA) reported a 3% decrease in net sales totaling $5.1 million for the first quarter of 2024 compared to the same period in 2023. The company reported a net loss of $252,412 and positive EBITDA of $89,723 for the quarter. Despite the decline in revenue, HealthWarehouse.com experienced a 7% growth in direct-to-consumer prescription sales. The company remains optimistic about future sales growth in 2024, focusing on new partnerships and recovering lost sales due to supply issues. HealthWarehouse.com continues to invest in technology to enhance operational efficiency and customer experience. Gross profit decreased by 10.0% due to lower sales and margins. Operating expenses decreased by 8.8% primarily in advertising, marketing, shipping, and salaries, offset by increased expenses in software engineering and stock-based compensation. The company reported a net loss of $252,000 for the quarter, an improvement from the previous year, and an Adjusted EBITDA of $90,000.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
HealthWarehouse.com, Inc. (HEWA) reports a 12% increase in revenues, reaching $20.3 million for the year ended December 31, 2023. The company experienced positive cash flow following the launch of new software, with a significant improvement in the second half of the year. Despite a net loss of $1.8 million, HealthWarehouse.com focuses on enhancing operational efficiency and customer experience for future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
HEWA: HealthWarehouse.com Reports 10% Increase in Prescription Revenues, Positive Cash Flow. Net sales for Q3 2023 were $4.8M, a 2% increase YoY. Prescription revenues increased by 10%, but a net loss of $299,000 was reported. The company remains focused on increasing access to healthcare products and investing in proprietary technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
HealthWarehouse.com, Inc. reports a 27% increase in revenues for the second quarter of 2023, reaching $5.3 million. The company also announced its inclusion in Forbes' list of best online pharmacies. However, HealthWarehouse.com experienced a net loss of $477,000 for the quarter and $825,000 for the six months ended June 30, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.53%
Tags
-
Rhea-AI Summary

HealthWarehouse.com, Inc. (OTCQB:HEWA) reported a 12% increase in net sales for 2022, totaling $18,142,633 driven by significant growth in partner services revenue. However, the company experienced a net loss of $952,029, worsening from $572,502 in 2021. Despite this, HealthWarehouse.com achieved positive cash flow for the sixth consecutive year with an Adjusted EBITDA of $146,787. Direct-to-consumer sales declined by 3.5%, while partner services revenue nearly doubled. Operating expenses rose by 10.7% to $12,725,433, largely due to increased shipping and salaries. The company plans to launch a new e-commerce platform in 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

HealthWarehouse.com, Inc. (OTC:HEWA) reported net sales of $4,681,302 for Q3 2022, an 11% increase from Q3 2021, driven by growth in partner services. The company recorded a loss from operations of $225,614, yet reported positive cash flow with an Adjusted EBITDA of $47,673. Prescription sales increased by 6.4% to $3,873,323, and OTC sales surged 46.2% to $736,265. Despite higher gross profit, operating expenses rose by 11.2%, leading to net losses slightly widening compared to last year. Future plans include launching a proprietary e-commerce platform aimed at improving customer retention.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.76%
Tags
none
Rhea-AI Summary

HealthWarehouse.com, Inc. (OTC:HEWA) reported a 6% revenue increase in Q2 2022, totaling $4,199,832, driven by growth in partner services. However, the company experienced operational losses of $293,524 for the quarter and $507,512 for the first half of the year. Prescription sales rose by 4.5%, while over-the-counter sales jumped by 18.1%. Despite the revenue growth, gross margins declined slightly, and operating expenses increased by nearly 10%. The company is planning to launch a new e-commerce platform in Q4 2022 and has been recognized as a Top Workplace in Greater Cincinnati.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
none

FAQ

What is the current stock price of HEALTHWAREHOUSE.COM (HEWA)?

The current stock price of HEALTHWAREHOUSE.COM (HEWA) is $0.08 as of December 24, 2024.

What is the market cap of HEALTHWAREHOUSE.COM (HEWA)?

The market cap of HEALTHWAREHOUSE.COM (HEWA) is approximately 5.0M.

What is HealthWarehouse.com?

HealthWarehouse.com is America's only VIPPS-certified mail-order pharmacy, licensed to operate in all 50 states.

Where is HealthWarehouse.com headquartered?

HealthWarehouse.com is headquartered in the Cincinnati metropolitan area.

What types of products does HealthWarehouse.com offer?

The company offers a wide range of FDA-approved prescription drugs and over-the-counter items, as well as medications found at veterinarian offices.

Is HealthWarehouse.com licensed in all states?

Yes, HealthWarehouse.com is licensed and authorized to operate in all 50 states.

What makes HealthWarehouse.com unique?

HealthWarehouse.com is the only verified internet pharmacy practice site in the U.S. and focuses on affordable healthcare.

How does HealthWarehouse.com ensure the quality of its products?

All products offered by HealthWarehouse.com are FDA-approved and legally verified for sale in the United States.

What is the mission of HealthWarehouse.com?

The mission is to provide affordable healthcare to every American.

Does HealthWarehouse.com offer medications for pets?

Yes, HealthWarehouse.com also carries medications that you would find at a veterinarian’s office.

How does HealthWarehouse.com prioritize customer service?

The company prides itself on offering personalized service from a highly skilled team of professionals dedicated to high-quality care.

What are some recent achievements of HealthWarehouse.com?

Recent achievements include expanding product lines and enhancing their online platform for better user experience.

HEALTHWAREHOUSE.COM

OTC:HEWA

HEWA Rankings

HEWA Stock Data

4.97M
55.27M
Pharmaceutical Retailers
Healthcare
Link
United States of America
Florence